onureg
bristol-myers squibb pharma eeig - azacitidina - leucemia, mieloide, acuta - agenti antineoplastici - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
vidaza 100 mg polvere per sospensione iniettabile
bristol-myers squibb sa - azacitidinum - polvere per sospensione iniettabile - preparazione cryodesiccata: azacitidinum 100 mg, mannitolum, per il vetro. - farmaco - synthetika
azacitidina hikma
hikma farmaceutica (portugal) s.a. -
azacitidin accord 100 mg pulver zur herstellung einer injektionssuspension
azacitidin accord 100 mg poudre pour la fabrication d'une suspension injectable
azacitidin sandoz 100 mg pulver zur herstellung einer injektionssuspension
azacitidin sandoz 100 mg poudre pour la fabrication d'une suspension injectable
azacitidin viatris 100 mg pulver zur herstellung einer injektionssuspension
azacitidin viatris 100 mg poudre pour la fabrication d'une suspension injectable